Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 53, Issue 11, Pages 4924-4926Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00786-09
Keywords
-
Categories
Funding
- Janssen Ortho/Ortho McNeil
Ask authors/readers for more resources
The in vitro activity of colistin was evaluated versus 3,480 isolates of gram-negative bacilli using CLSI broth microdilution methods. The MIC(90) of colistin was <= 2 mu g/ml against a variety of clinically important gram-negative bacilli, including Escherichia coli, Klebsiella spp., Enterobacter spp., Acinetobacter baumannii, and Pseudomonas aeruginosa. All multidrug-resistant (n = 76) P. aeruginosa isolates were susceptible to colistin (MIC, <= 2 mu g/ml). These data support a role for colistin in the treatment of infections caused by multidrug-resistant P. aeruginosa.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available